Related references
Note: Only part of the references are listed.The reactome pathway knowledgebase
Bijay Jassal et al.
NUCLEIC ACIDS RESEARCH (2020)
Tumour metabolism and its unique properties in prostate adenocarcinoma
David A. Bader et al.
NATURE REVIEWS UROLOGY (2020)
Association between focal adhesion kinase and matrix metalloproteinase-9 expression in prostate adenocarcinoma and their influence on the progression of prostatic adenocarcinoma
Alev Ok Atilgan et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Boris Y. Shorning et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
SignalP 5.0 improves signal peptide predictions using deep neural networks
Jose Juan Almagro Armenteros et al.
NATURE BIOTECHNOLOGY (2019)
Mitochondrial oncobioenergetics of prostate tumorigenesis
Praveen Kumar Vayalil
ONCOLOGY LETTERS (2019)
Identification of key genes in prostate cancer gene expression profile by bioinformatics
Wenzong Lu et al.
ANDROLOGIA (2019)
Identification of key genes and multiple molecular pathways of metastatic process in prostate cancer
Lihuang Guo et al.
PEERJ (2019)
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2019)
Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis
Laura Foj et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer
Yun Ye et al.
PLOS ONE (2018)
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
Janet Pinero et al.
NUCLEIC ACIDS RESEARCH (2017)
Glucose Metabolism in the Progression of Prostate Cancer
Francesca Cutruzzola et al.
FRONTIERS IN PHYSIOLOGY (2017)
AR Signaling and the PI3K Pathway in Prostate Cancer
Megan Crumbaker et al.
CANCERS (2017)
Urinary osteopontin as a marker for localized and metastatic prostate cancer.
A. J. Prager et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
Kazutoshi Fujita et al.
SCIENTIFIC REPORTS (2017)
A comprehensive analysis and annotation of human normal urinary proteome
Mindi Zhao et al.
SCIENTIFIC REPORTS (2017)
A re-examination of the role of the acute phase protein response in innate cancer defence
David M. Conrad et al.
MEDICAL HYPOTHESES (2016)
Bioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics data
Chen Chen et al.
ONCOTARGETS AND THERAPY (2016)
Novel biomarkers for the detection of prostate cancer
Niels Asger Jakobsen et al.
JOURNAL OF CLINICAL UROLOGY (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
Shuhua Yue et al.
CELL METABOLISM (2014)
Development of an ELISA for sPSP94 and utility of the sPSP94/sPSA ratio as a diagnostic indicator to differentiate between benign prostatic hyperplasia and prostate cancer
Deepa R. Mhatre et al.
CLINICA CHIMICA ACTA (2014)
Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis
Isabel Heidegger et al.
ONCOTARGET (2014)
Correlation and diagnostic performance of the prostate-specific antigen level with the diagnosis, aggressiveness, and bone metastasis of prostate cancer in clinical practice
Bannakij Lojanapiwat et al.
PROSTATE INTERNATIONAL (2014)
Levels of Beta-Microseminoprotein in Blood and Risk of Prostate Cancer in Multiple Populations
Christopher A. Haiman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Proteomic studies of urinary biomarkers for prostate, bladder and kidney cancers
Steven L. Wood et al.
NATURE REVIEWS UROLOGY (2013)
Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids
Nousheen Zaidi et al.
PROGRESS IN LIPID RESEARCH (2013)
Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer
Ioannis Katafigiotis et al.
BJU INTERNATIONAL (2012)
Focal Adhesion Kinase Controls Prostate Cancer Progression Via Intrinsic Kinase and Scaffolding Functions
Sheila Figel et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis
Anna Dahlman et al.
MODERN PATHOLOGY (2011)
The Discovery of Putative Urine Markers for the Specific Detection of Prostate Tumor by Integrative Mining of Public Genomic Profiles
Min Chen et al.
PLOS ONE (2011)
A Common Prostate Cancer Risk Variant 5′ of Microseminoprotein-β (MSMB) Is a Strong Predictor of Circulating β-Microseminoprotein (MSP) Levels in Multiple Populations
Kevin M. Waters et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Association of cysteine-rich secretory protein 3 and β-microseminoprotein with outcome after radical prostatectomy
Anders S. Bjartell et al.
CLINICAL CANCER RESEARCH (2007)
The insulin-like growth factor 1 receptor in cancer: Old focus, new future
Hermien Hartog et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy
Jonathan R. Reeves et al.
CLINICAL CANCER RESEARCH (2006)
Quantification of fragments of human serum inter-α-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay
Jin Song et al.
CLINICAL CHEMISTRY (2006)
A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis
RK Nam et al.
JOURNAL OF UROLOGY (2006)
Human urine proteome analysis by three separation approaches
W Sun et al.
PROTEOMICS (2005)
Increased intratumoral expression of prostate secretory protein of 94 amino acids predicts for worse disease recurrence and progression after radical prostatectomy in patients with prostate cancer
AR Girvan et al.
UROLOGY (2005)
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells
G Pandini et al.
CANCER RESEARCH (2005)
Insulin-like growth factor ligands, receptors, and binding proteins in cancer
E Foulstone et al.
JOURNAL OF PATHOLOGY (2005)
Feature-based prediction of non-classical and leaderless protein secretion
JD Bendtsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Characterization of the human urinary proteome: A method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots
R Pieper et al.
PROTEOMICS (2004)
Variation of serum prostate-specific antigen levels - An evaluation of year-to-year fluctuations
JA Eastham et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Cytoscape: A software environment for integrated models of biomolecular interaction networks
P Shannon et al.
GENOME RESEARCH (2003)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
KEGG: Kyoto Encyclopedia of Genes and Genomes
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
